Physician

Jordan Andrew Henderson, D.O.

According to 2025 Medicare claims, Jordan Henderson, D.O. (NPI: 1013200328) practices hematology/oncology in the Myrtle Beach-Conway-North Myrtle Beach, SC market, with the plurality of this provider's patient population coming from Horry, SC. This provider's primary affiliated billing organization is COASTAL CANCER CENTER LLC (NPI: 1881614170; TIN: 570777346) and primary practice location at 29572-4128.

Henderson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,085 traditional Medicare patients, billed 383,881 HCPCS/CPT codes, and received $7,954,128 in Medicare payments. The top billing code was 36415 (Insertion of needle into vein for collection of blood sample). Part D data shows 1,018 prescription claims across 232 beneficiaries totaling $4,713,187 in drug costs, led by Revlimid (Lenalidomide). DME data shows 92 claims. Open Payments data shows 43 records totaling $1,177. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $5,099 to $7,954,128. Similarly, Part D prescription costs have risen steadily, from $105,097 to $4,713,187. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $661 to $1,420.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	33	47	$5,099
2016	N/R	N/R	N/R
2017	851	177,787	$1,120,956
2018	1,519	523,022	$4,073,059
2019	1,102	379,523	$3,444,544
2020	1,168	349,147	$3,508,472
2021	1,482	414,151	$4,909,696
2022	1,364	287,840	$4,402,838
2023	1,177	357,240	$5,613,594
2024	1,085	383,881	$7,954,128

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	45	104	$105,097
2016	39	106	$7,799
2017	87	238	$12,675
2018	196	776	$1,165,902
2019	188	955	$1,720,105
2020	188	883	$3,181,767
2021	193	895	$3,772,961
2022	203	892	$3,813,819
2023	206	917	$3,653,435
2024	232	1,018	$4,713,187

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	25	$4,794
2019	11	133	$97,777
2020	N/R	29	$2,929
2021	N/R	55	$3,964
2022	N/R	43	$1,906
2023	N/R	92	$17,575
2024	N/R	92	$2,021

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
36415	Insertion of needle into vein for collection of blood sample	777	3,006	$9
80076	Liver function blood test panel	675	2,028	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	779	3,004	$8
82565	Blood creatinine level	674	2,029	$5
82435	Blood chloride level	673	2,025	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	42	1,162	$780,135
Lenalidomide	Lenalidomide	46	1,218	$629,197
Pomalyst	Pomalidomide	20	560	$442,362
Imbruvica	Ibrutinib	19	700	$385,780
Xtandi	Enzalutamide	17	510	$235,280

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	27	$879
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	29	$527
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	12	$337
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	13	$163
E0562	Humidifier, heated, used with positive airway pressure device	Y	N/R	11	$116

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$1,177	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jordan Andrew Henderson, D.O.?

Tedicare shows public-source Medicare data for Jordan Andrew Henderson, D.O. (NPI 1013200328), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jordan Andrew Henderson, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jordan Andrew Henderson, D.O.?

Jordan Andrew Henderson, D.O. is linked to COASTAL CANCER CENTER LLC (billing NPI 1881614170) in the available physician profile data.

Does Jordan Andrew Henderson, D.O. have Open Payments data?

Jordan Andrew Henderson, D.O. has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.